Skip to content

Clinical trials

Phase 3 Dwarfism, Pituitary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dwarfism, Pituitary Phase: Phase 3 Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20036
20043
20053
20062
20072
20081
20092
20103
20131
20141
20155
20161
20175
20193
20201
20212
20232
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Terminated6
Unknown status5
Recruiting3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S8
Pfizer7
Ascendis Pharma Endocrinology Division A/S4
Changchun GeneScience Pharmaceutical Co., Ltd.3
Eli Lilly and Company3
LG Life Sciences3
AEterna Zentaris2
EMD Serono2
Federico II University2
Lumos Pharma2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dwarfism, Pituitary52
Endocrine System Diseases6
Pituitary Diseases6
Failure to Thrive5
Brain Concussion1
Diabetes Mellitus1
Growth Disorders1
Heart Failure1
Obesity1

Trials

Showing 76 to 52 of 52. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.